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ABSTRACT
Objective: To provide a new perspective on integrated biomedical and psychosocial demen-
tia research.
Background: Dementia is being recognized as a multifactorial syndrome, but there is little inter-
action between biomedical and psychosocial approaches. A way to improve scientific knowledge is
to seek better understanding of the mechanisms underlying the interaction between biomedical
and psychosocial paradigms. One rationale for integrating biomedical and psychosocial research is
the discordance between neuropathology and cognitive functioning. The concept of social health
might bridge the two paradigms. It relates to how social resources influence the dynamic balance
between capacities and limitations.
Hypotheses: Social health can act as the driver for accessing cognitive reserve, in people with
dementia through active facilitation and utilization of social and environmental resources. Thereby
we link lifestyle social and opportunities to the brain reserve hypothesis.
Manifesto: We provide a Manifesto on how to significantly move forward the dementia
research agenda.
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Dementia has physical, psychological, social, and economic
consequences for people with dementia, their carers, fami-
lies, and society at large (World Health Organisation, 2017).
In Europe 10 million people had dementia in 2010 and this
number is expected to rise to 19 million by 2050 (Prince
et al., 2013).
Despite dementia being recognized as a multifactorial
syndrome (Winblad et al., 2016), research to date appears to
have developed with little interaction or cross-fertilization
between biomedical and psychosocial approaches, each
overlooking potential influential factors from the other to
the detriment of both paradigms. This perspective article
contributes to the dementia debate by outlining an in-depth
perspective on interdisciplinary dementia research.
Biomedical research has undoubtedly led to better
understanding of the ageing brain. It has focused on the
search for a curative treatment for dementia, but despite
huge efforts this is proving challenging (Winblad et al.,
2016). Psychosocial research has had some success in the
development of effective interventions and improvements
in care practice. It has also made progress in considering
how people with dementia, carers and the public can
themselves guide new research (Gove et al., 2018). The
focus, vision and ambition of psychosocial dementia
research, has been strongly influenced by the European
INTERDEM (Early detection and timely INTERvention in
DEMentia) network (www.interdem.org) and its initial 2011
Manifesto (Moniz-Cook, Vernooij-Dassen, Woods, & Orrell,
2011). INTERDEM is a pan-European network of dementia
researchers aiming at improving the quality of life of peo-
ple with dementia and their supporters across Europe.
However, little research has been conducted to inform the
underlying mechanisms of changes associated with demen-
tia pathology and there is an underinvestment in the role
of social factors in dementia research. Given the huge
impact of dementia worldwide, and the absence to date of
a significant breakthrough in curative research, a way for-
ward may be to seek better understanding the interaction
between biomedical and psychosocial paradigms.
The rationale for integrating biomedical and psycho-
social research is the discordance between neuropathology
and cognitive functioning (Winblad et al., 2016). This
means that although the role of biomarkers is significant,
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they do not account for all clinical and epidemiological
aspects of disease onset and progression. Epidemiological
data revealed that clinical features of the disease are also
influenced by other factors, including social factors, which
modulate disease onset and progression (Hersi et al., 2017;
Livingston et al., 2017)
We explore new ideas for the pathogenesis of AD
through connecting biomedical and psychosocial
approaches. We also examine new avenues on how people
with dementia and their families can live as well as they
can, irrespective of dementia pathology. This can also con-
tribute to prevention of disability and dementia.
The aim is to provide a new perspective on integrated
biomedical and psychosocial dementia research. First, we
examine the strengths and limitations of biomedical and
psychosocial approaches to date. Next, we consider the
rationale for integration of relevant aspects of the two
paradigms. We consider hypotheses-led research related to
the underlying interaction between biomedical and psy-
chosocial concepts such as cognitive reserve and social
health. We conclude with a call for action in a new mani-
festo and a refreshed research agenda for dementia
research over the next five years.
INTERDEM (Early detection and timely INTERvention in DEMentia)
www.interdem.org) is a European organisation of psychosocial
dementia researchers. It has more than 200 members including psy-
chologists, medical doctors, nurses, sociologists and health scientists.
Activities include joint research and articles, special issues on social
health and person-centred care and taskforces on methodology,
social health, technology and prevention. INTERDEM takes responsi-
bility in addressing key research issues related to dementia, such as
outcomes, personalized care and multidisciplinary research. There is
a strong connection with Alzheimer Europe and the Patient and
Public Involvement. INTERDEM has initiated an Academy to help
develop and train early-career researchers to carry out high-quality
research in this field. The INTERDEM Academy gives access to a
comprehensive research training program that deepens the under-
standing of the nature of dementia and trains young researchers in
methodological excellence, creative innovation and intellec-
tual leadership.
Strengths and limitations of
biomedical approaches
For most of the twentieth century, Alzheimer’s disease was
considered as a pre-senile dementia, affecting people aged
below 65 years. In this way, it was conceptualized as dis-
tinct from senile dementia, which was viewed to be the
result of ageing. The identification of post-mortem brain
pathology in people with senile dementia in the late 1960s
(Blessed, Tomlinson, & Roth, 1968), led to redefinition of
dementia occurring at any age as Alzheimer’s disease and
the framing as a true brain disease (Katzman, 1976).
Conceptualizing dementia as a brain disease rather than a
consequence of ageing has engendered a political agenda
with enormous global consequences, for science and soci-
ety, powerfully driving research, awareness and social atti-
tudes. While ageing calls for acceptance and a supportive
approach, a disease calls for active interventions, which can
potentially be curative. The expectation that neurobio-
logical research would lead to a rational treatment resulted
in an exponential growth of this branch of science, applied
to neurodegeneration. A strength of this approach is that
progress in biomedical research has led to a better under-
standing of the ageing brain and a diversity of theories
about ageing and dementia. However, a consequence of
the dominance of the neurobiological approach is a poten-
tial disconnect from the lived experience of the condition.
Recent research criteria of the National Institute on Aging
and Alzheimer’s Association (NIA-AA) propose that a diag-
nosis of Alzheimer’s disease is made on the basis of evi-
dence of neuronal atrophy or injury and biomarkers (Jack
et al., 2018), even in people who lack any signs or symp-
toms of cognitive deterioration. This has led to the notion
of asymptomatic Alzheimer’s disease. The authors acknow-
ledge that diagnostic biomarker criteria are recommended
for research purposes and are not yet ‘ready’ for clinical
diagnostics.
However, the attention on deficits rather than capacities,
especially in public campaigns, has increased the sense of
hopelessness associated with dementia. Accordingly,
dementia has now replaced cancer as the most feared
health condition for people over the age of 50
(Department of Health England, 2013). More disturbingly,
no effective treatment is available today, and there is little
outlook of one (Drachman, 2014; Selkoe, 2019). Therefore,
redefinition of Alzheimer’s disease and new avenues to bet-
ter deal with the dementia syndrome are needed. A major
limitation of this pathology-led approach to Alzheimer’s
disease is that it overlooks the potential of brain resilience
and ignores two major problems associated with a classic
disease model (Richards & Brayne, 2010). Firstly, there is no
consistent relationship between the clinical features and
many of the neurobiological hallmarks of Alzheimer’s dis-
ease, and plaques and tangles are not pathognomonic.
Nearly 50% of very old people with dementia did not have
sufficient brain neuropathology to explain their cognitive
symptom (Balasubramanian, Kawas, Peltz, Brookmeyer, &
Corrada, 2012). Another striking finding is that high levels
of AD pathology were present in one third of very old peo-
ple without dementia (Corrada, Berlau, & Kawas, 2012).
Secondly, in these age groups, pathology is far more het-
erogeneous than previously believed, with a mixture of pla-
ques and tangles and cerebrovascular disease, even in
patients who are clinically diagnosed with probable
Alzheimer’s disease (Richards & Brayne, 2010).
There seems to be emerging epidemiological consensus
that lifestyle factors are important avenues of prevention,
and are therefore relevant to treatment (Fratiglioni,
Paillard-Borg, & Winblad, 2004; Kuiper et al., 2015; Salinas
et al., 2017). This provides common ground for prevention
interventions and new perspectives to influence the course
of dementia.
Instead of focusing primarily on biomarkers and brain
imaging, it is time to apply a more comprehensive model
of dementia, encompassing the relationship between the
variety of biological, psychological and social factors.
Strengths and limitations of
psychosocial approaches
Psychosocial interventions
Since the publication of the first INTERDEM manifesto
(Moniz-Cook et al., 2011), there has been considerable pro-
gress in the development and rigorous evaluation of psy-
chosocial interventions in dementia.
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Most psychosocial interventions in dementia are at a
micro-level, relating to small-scale interactions between
individuals. The strength of these interventions is that they
can reduce excess disability and stimulate the person with
dementia to make to most of their underlying capabilities,
including cognitive functioning, skills and function, to com-
pensate for limitations and assist with mood and emotion
regulation. These approaches do not have harmful side
effects and several approaches have been proved to be
effective. Multi-component exercise and cognitive stimula-
tion as well as functional analysis-based interventions have
worthwhile benefits for people with dementia related to
cognition, behavior, daily functioning and quality of life
(McDermott et al., 2018). Psychosocial approaches are,
together with pharmacological options, now part of main-
stream dementia care. Palliative care interventions in
dementia focus on person-centered support, and living and
dying well with dementia (The Lancet, 2018). Recent exam-
ples of effective interventions include educational training
in nursing homes and in general practice (Smets et al.,
2018; Tilburgs et al., 2018).
Moreover, psychosocial interventions used the potential
of assistive technology and showed that technology offers
promising ways to tailor accessibility, personalization and
sustainability of interventions from prevention to palliative
care (Meiland et al., 2017). Cost–effectiveness of psycho-
social interventions is strongly influenced by their potential
to improve quality of life and to reduce costly hospital or
care home admissions. Specialist personalized, multicompo-
nent psychological support to family carers, have been
shown to reduce the frequency of care home admissions
(Livingston et al., 2017). Projects facilitated by INTERDEM
have examined cross-national implementation of cost-
effective interventions such as meeting centers (Brooker
et al., 2018).
Psychosocial interventions can also support family carers
affected by dementia (World Health Organisation, 2012).
Multicomponent interventions including personal carer
focused interventions can reduce depressive symptoms
and improve quality of life in carers, reduce carer burden,
and reduce behavioral and psychological symptoms of
dementia as well as carer upset with these symptoms
(Laver, Milte, Dyer, & Crotty, 2017).
The wealth of initiatives is promising. Evaluation reveals
the value of person-centered and multi-component
approaches, the consideration of the societal context and
the attention for carers. These approaches should be pre-
served and enhanced. Effective approaches should be
implemented systematically.
However, there are limitations that require mitigation.
Not all interventions have proven effective, and it is often
difficult to implement interventions widely.
The use of technologies evoked concerns about the reli-
ability of the technology and acceptability by users and
professionals (Meiland et al., 2017). New paradigms for
evaluating effectiveness are required, with the Internet and
technologies moving on too quickly to afford the luxury of
a randomized controlled trial lasting several years. Thus,
Van der Roest, Wenborn, Pastink, Droes, and Orrell (2017)
were unable to identify any RCTs of assistive technology
for supporting memory in people with dementia.
Whilst some interventions have significant effects, in
absolute terms the effects may be relatively small for a
given individual, in comparison with the scale of changes
being experienced. A robust finding is that more personal-
ized interventions are most effective, with evidence that
‘one size does not fit all’ (Brodaty, Green, & Koschera, 2003;
Kim & Park, 2017; Van Mierlo, Van der Roest, Meiland, &
Droes, 2010). Research to date has often not been inform-
ative enough about who will benefit most from a specific
intervention. The challenge comes from identifying what
will be helpful for a particular individual living with demen-
tia, rather than the effects on the average person. To move
forward in dementia research, better methodology using
theoretical models may enhance knowledge on why and
how interventions work or fail in relation to dementia
(Vernooij-Dassen & Moniz-Cook, 2014). It also requires a
shift in methodology to collect evidence in a more person-
alized way with sensitivity to context, biomedical informa-
tion and individual goals. Goal setting approaches are an
example of how this could be practically achieved (Clare
et al., 2019). Adaptations at this personalized level are in
line with the personalized medicine agenda. A key barrier
to current psychosocial dementia research is the lack of
integration with biological models. Finally, in the psycho-
social field, effective approaches are implemented sporadic-
ally at best, and differences in culture, language and care
systems between and within countries mean that transfer-
ring findings from one context to another requires careful
planning and evaluation (Aguirre, Spector, & Orrell, 2014;
Spector et al., 2019).
The current interventions aim at restoring ‘lost capaci-
ties’. New perspectives for psychosocial interventions shift
the focus to ‘remaining capacities’. These perspectives
include better use of public and patient involvement (PPI),
more attention for the potential of social health and more
attention for dementia pathology by better integration
with biomedical research. These are all fields in develop-
ment. In the following sections, we explain more on
their potential.
Public and patient involvement
Public and patient involvement provides an avenue for
people with dementia to confirm their place in society. The
negative framing of dementia in public discourse as a
scourge, dread disease, avalanche, apocalypse, plague, epi-
demic, or living death is challenged by the growing inter-
national, national and local communities of people living
with dementia who self-advocate. They take their place in
the dementia debate, asserting: ‘Nothing about us without
us’. Psychosocial research has embraced the development
of this movement, often working with Alzheimer organiza-
tions such as Alzheimer Europe and national Alzheimer
societies. Accordingly, INTERDEM has a Memorandum of
Understanding with Alzheimer Europe confirming the col-
laboration with regards to PPI. Alzheimer Europe’s position
statement on PPI in research outlines the potential for
wide-ranging activities for people with dementia and those
that support them, such as acting as consultants, identify-
ing research topic priorities, contributing to ethical debates,
interpretation of findings and dissemination (Gove et al.,
2018). The research agenda has already benefited from the
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involvement of people with dementia and their supporters,
especially in the UK (Bethell et al., 2018; Miah et al., 2019).
New initiatives in the psychosocial arena aim to engage
the public and wider society in dealing with dementia in
daily life and to change the negative framing and stigma.
They acknowledge the right to live well with dementia and
relate to ‘normal life’. On the meso-level of communities
and organizations training interventions are seen for staff
working in a variety of organizations, such as banks, super-
markets, transport providers and police; and art galleries
and cinemas have ‘dementia friendly’ events.
Neighborhood and Civil initiatives (Dementia Friends) are
in place including Dementia friendly communities
(Alzheimer Europe, 2015).These initiatives have out-paced
related research, but projects are now commencing e.g.
the Social citizenship UK project (Ward et al., 2018). On a
macro-level new initiatives include television commercials
on how to deal with people with dementia, and govern-
mental campaigns to focus attention on dignity (Dutch
Ministry of Health, 2015). Around the world 81% of coun-
tries participating in the WHO Global Dementia
Observatory initiative have a dementia awareness cam-
paign (The Lancet, 2017). There are numerous novels, plays,
films and even operas in which dementia is depicted as a
central theme, with dementia now receiving almost as
much attention in arts and culture as in the health and
care sector.
Social health
In dementia, people more than ever require to depend on
other persons, not only for practical support, but also to
find a balance between their capacities and limitations.
However, there is an underinvestment in studying the role
of social influences, even within psychosocial interventions.
There is a need for an overarching lens through which
studies of social influences on dementia can be brought
into focus (Vernooij-Dassen & Jeon, 2016). The concept of
social health provides an umbrella to study how social
resources influence the dynamic balance between capaci-
ties and limitations. The dimensions of social health include
the capacity to fulfill potential and obligations, to manage
life with some degree of independence and to participate
in social activities (Huber et al., 2011). Applying the social
health concept to dementia research allows improved
understanding of how people, their social networks and
wider society with its norms, interact with the condition.
For example, more time spent with others and better com-
munication were associated with better ADL functioning
across all dementia severity (Budgett et al., 2019). An
important new finding is that sensitivity to others did not
differ between dementia severity levels and was a pre-
served domain throughout dementia (Budgett et al.,
2019).This potential facilitates fulfilling social obligations
and interventions can draw on these retained resources.
On a biological level, greater emotional support was found
to be associated with higher brain-derived neurotropic fac-
tor (BDNF). BDNF is a neuroprotective molecule, critical for
synaptic plasticity and neuronal repair (Salinas et al., 2017).
Social health connects both to normalcy and to neuro-
pathology (Vernooij-Dassen & Jeon, 2016). Moreover, the
introduction of the concept of social health in dementia
research provides a recognizable label for communication
and synergy scientific paradigms in dementia research.
INTERDEM has championed social health in dementia
research, bringing together two special issues in relevant
journals on this topic. This has harnessed a growing
research agenda (de Vugt & Dr€oes, 2017) and includes a
consensus-based inventory of concepts under the umbrella
of social health, from the work of the INTERDEM taskforce
on Social Health (Dr€oes et al., 2017). The social experiences
of people with dementia and the dynamics within social
networks are now being described (Vernooij-Dassen,
Moniz-Cook, & Jeon, 2018). For example, an investigation
of lived experiences revealed that people with dementia
can feel they are being treated as an ‘other’ rather than
‘one of us’, and as ‘lesser’ rather than a full, valued member
of society (Patterson, Clarke, Wolverson, & Moniz-Cook,
2018). Fear of being unable to communicate according to
accepted norms and the shame of revealing deterioration
has been shown to prevent people with dementia from
engaging in social contacts (Donkers et al., 2018).
These examples of social health studies in dementia
show its huge potential in the understanding of modifiable
factors associated with the onset and course of dementia.
Bridging biomedical and psychosocial research
in dementia
Biomedical and psychosocial approaches continue to
develop separately from each other. Although each has
developed into fruitful disciplines, there is the danger of
inconsistency and tunnel vision. The focus of this current
manifesto is to propose that the zeitgeist of dementia
research moves to a more integrative bio-psychosocial
approach, since this does greater justice to phenomen-
ology and pathology of people living with dementia. The
strength of the separate approaches provide the clues for
an integrative approach by indicating a range of protective
and compensatory factors. Certain compensatory factors
(e.g. high education, social engagement, maintenance of
cardiovascular health and mentally stimulating activities)
enhance cognitive and brain reserve. Emerging epidemio-
logical evidence suggests that higher levels of social par-
ticipation reduce occurrence and progression of cognitive
impairment and dementia (Fratiglioni et al., 2004; Kuiper
et al., 2015; Salinas et al., 2017). Social health factors can
influence brain structure (Kwak, Joo, Youm, & Chey, 2018)
and may contribute to brain reserve and enhance the plas-
ticity of the brain (Fratiglioni & Wang, 2007). The brain
reserve hypothesis refers to the capacity of the brain to
resist the impact of brain pathology through plasticity that
uses pre-existing cognitive processes or by activating com-
pensatory approaches (Fratiglioni & Wang, 2007; Qiu &
Fratiglioni, 2018). This opens avenues for influencing the
onset, and the course of dementia.
A framework to study the integration of biomedical and
psychosocial factors is positive health. Applying the frame-
work of positive health to dementia allows a focus on both
capacities and deficits and on the ability to adapt and self-
manage by connecting the three constituent domains:
physical, mental and social health (Huber et al., 2011). We
hypothesize that social health can act as the driver for
accessing cognitive reserve in people with dementia,
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through active facilitation and utilization of social and
environmental resources. Herewith we relate to the brain
hypothesis (Fratiglioni & Wang, 2007). Social interactions
may trigger reactions, which might require the use of pre-
existing cognitive processes or activating compensatory
approaches (Fratiglioni & Wang, 2007).
Our hypothesis will guide two new ambitious interdis-
ciplinary dementia studies: the study on the influence of
social health on the onset of dementia (Kas et al., 2018)
and on the course of dementia (Ikram et al., 2019). The
hypothesis might also stimulate current clinical practice
and civic interaction by focusing on assets or capacities
rather than limiting work to deficit or needs-based models.
This may stimulate social inclusion and prevent
social withdrawal.
Often, new insights are incremental involving small
steps: in this case hypothesis-led integration of biomedical
and psychosocial research and the inclusion of underex-
plored paradigms such as social health. Good examples of
this unified approach are to be found in epidemiological
work on risk factors for dementia, where we see genetic
risk factors having an influence alongside biomedical
aspects, such as hypertension, in combination with psycho-
social influences, such as smaller social networks
(Livingston et al., 2017). The unified approach may also
help to underpin new personalized diagnostic and thera-
peutic strategies and reveal opportunities for more effect-
ive interventions through interruption of the vicious cycle
of ‘malignant social psychology’ cycle which Kitwood
(1997) argued could be linked to neurological impairment.
Call to Action: the 2019 INTERDEM Manifesto. To signifi-
cantly move forward the dementia research agenda in the
next five years we call for:
1. Work on approaches and concepts at the interface of
biomedical and psychosocial approaches, thus all poten-
tial domains are utilized fully – social, psychological
and physical. This will need recognition of common
ground, developing better communication and under-
standing of the contributions from different fields.
Bridging this gap has the potential for progressing
knowledge on preventing and delaying the dementias.
2. Recognition of social health as a specific area for devel-
opment. This has huge potential for informing new
interventions that may prevent or delay the onset of
dementia. Both psychosocial and biomedical
approaches need to be engaged across the spectrum
of the conditions and severity, from prevention to pal-
liative care, where physical health, pain and co-morbid
health conditions are major influences on quality of
life and well-being.
3. Development of models of co-production in dementia
research. The research agenda has already benefited
from the involvement of people with dementia and
their supporters, but further progress towards partner-
ship and co-production is needed. Some areas of
research such as advanced dementia and palliative
care may require new models of involvement
and engagement.
4. Harnessing the power of new technology to the benefit
of people with dementia.
New technology may be effective for prevention,
making the diagnosis, and helping people with
dementia with the physical, psychological and social
consequences of the disease. It offers ways to tailor
accessibility, personalization and sustainability of inter-
ventions from prevention to palliative care.
As new cohorts of people develop dementia, with
greater familiarity with technology, the potential will
grow further, and a balance must be sought between
bespoke solutions (including care robots) and the
widespread use of ubiquitous technologies (such as
smart phones). From a research perspective, new para-
digms for evaluating effectiveness are required.
5. Interventions to be individualized. This is an area of
common ground for psychosocial and biomedical
paradigms offering the opportunity to develop person-
alized approaches to evaluation and recognizing that
targets for health and social care will not be the same
for different individuals. Methods of outcome assess-
ment could be coordinated across biomedical and psy-
chosocial approaches. Goal setting approaches are an
example of how this could be practically achieved. If
the mechanisms of change for individual cases can be
understood more fully, then there is the scope for
making progress in relation to what works for whom,
when and where.
6. Greater attention to implementation of research findings.
In the psychosocial field, effective approaches are
implemented sporadically at best, and differences in
culture, language and care systems between and
within countries mean that transferring findings from
one context to another requires careful planning and
evaluation. Care research needs to be related to
National Dementia Plans, and country specific priorities
such as coordination of care in countries with many
care facilities and access to treatment in countries with
poor facilities must be addressed. The input of people
living with dementia and carers will be essential
here also.
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